You or someone you care for has been prescribed Kovaltry to help manage hemophilia A.
Explore this site to learn more about Kovaltry and better understand your treatment.
Kovaltry is used for treatment and prevention (prophylaxis) of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
- It is also used for prophylaxis treatment of children with hemophilia A to reduce the occurrence of spontaneous bleeding episodes.
- This preparation does not contain von Willebrand factor and is therefore not to be used in von Willebrand's disease.
Want more information on Kovaltry?
Please refer to the package insert included with Kovaltry.
You can also speak with your healthcare professional or contact Bayer Medical Information by email at canada.medinfo@bayer.com or by calling 1-800-265-7382 (7:30 am to 7:30 pm, EST).